A retrospective cohort study explored outcomes for pregnant women with HL who received antenatal chemotherapy compared with a match cohort of nonpregnant women.
Study sought to determine if response to upfront treatment in children and adolescents with Hodgkin lymphoma is influenced by race/ethnicity.
A single-center retrospective cohort analysis revealed real-world insights into possible treatments for elderly patients with Hodgkin lymphoma.
Certain malignancies, younger age at diagnosis, and multiple affected relatives were all associated with increased familial relative risks.
Researchers reported follow-up data for patients with advanced-stage Hodgkin lymphoma evaluated for response with positron emission tomography scanning.
A classic Hodgkin lymphoma patient had a false-positive PET, leading to unneeded workup.
Interpreting PET scores according to established criteria is crucial for guiding treatment following initial chemotherapy in early-stage disease.
Though lymphoproliferative diseases during pregnancy can lead to complications, a host of treatment options exists.
The purpose of this study is to assess the safety, tolerability, and antitumor activity, as well as recommended dose of brentuximab vedotin in combination with a multiagent chemotherapy regimen.
With numerous options, there is growing debate over the frontline treatment of Hodgkin lymphoma.
